Atara Biotherapeutics, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 0 0 20 64 9 129
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% 212.6% -86.5% 1404.0%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -inf% -inf% 44.1% 77.1% -3.7% 83.7%
EBIT (mln) -3 -9 -28 -58 -81 -122 -237 -296 -309 -340 -281 -269 -83
EBIT Δ r/r 0.0% 167.1% 226.8% 107.6% 39.0% 49.6% 95.1% 24.7% 4.5% 10.2% -17.6% -4.0% -69.0%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -1673.9% -441.2% -3141.0% -64.7%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 2 5 5
EBITDA (mln) -4 -9 -28 -58 -81 -122 -237 -296 -309 -340 -331 -264 -83
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -1673.9% -520.3% -3084.6% -64.7%
Podatek (mln) 0 0 -0 -0 0 -0 -0 0 0 0 0 0 -0
Zysk Netto (mln) -123 -9 -28 -57 -79 -119 -231 -291 -307 -340 -228 -276 -85
Zysk netto Δ r/r 0.0% -92.9% 219.2% 104.3% 38.1% 51.2% 93.1% 26.1% 5.4% 10.9% -32.9% 20.9% -69.1%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -1672.3% -359.1% -3220.9% -66.2%
EPS -16.81 -1.28 -5.62 -2.24 -2.75 -4.0 -5.27 -5.67 -4.15 -3.63 -2.24 -2.61 -11.41
EPS (rozwodnione) -16.81 -1.28 -5.62 -2.24 -2.75 -4.0 -5.27 -5.67 -4.15 -3.63 -2.24 -2.61 -11.41
Ilośc akcji (mln) 1 7 5 26 29 30 44 51 74 94 102 106 7
Ważona ilośc akcji (mln) 1 7 5 26 29 30 44 51 74 94 102 106 7
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD